Application 090986
- Type
- ANDA
- Sponsor
- WOCKHARDT USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.2MG BASE/ML | No | No |
| 002 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090986-001 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | ||
| A090986-002 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090986-001 | OCTREOTIDE ACETATE | EQ 0.2MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090986-002 | OCTREOTIDE ACETATE | EQ 1MG BASE/ML | INJECTABLE / INJECTION | 2011-05-11 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sandostatin | OCTREOTIDE ACETATE | Novartis Pharmaceuticals Corporation | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 2026-07-22 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | GLENMARK PHARMACEUTICALS INC., USA | 387d7f8d-9762-4f6b-99e1-bdc50b8a1633 | 2026-01-30 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | Mylan Institutional LLC | e5c21813-4714-4f23-be8b-765bd58f63b3 | 2026-01-21 | Warnings, Adverse reactions | OCTREOTIDE ACETATE OCTREOTIDE ACETATE |
| Sandostatin LAR Depot | OCTREOTIDE ACETATE | Novartis Pharmaceuticals Corporation | d0b7fe9e-7000-4b79-ba3b-291ce92c14f9 | 2025-12-22 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | ab9b0d3d-4dab-4c5b-9c23-3a14f8fcfcde | 2025-06-25 | Warnings, Adverse reactions | OCTREOTIDE ACETATE OCTREOTIDE ACETATE |
| BYNFEZIA Pen | OCTREOTIDE ACETATE | Sun Pharmaceutical Industries, Inc. | 20ed4e79-ad4c-426f-859d-83790c00439b | 2025-02-21 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Meitheal Pharmaceuticals, Inc. | 01962c67-e551-47b6-a276-e1ae1860d2a4 | 2025-01-16 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ffaf9462-cdd8-433b-8b03-464a35577fe9 | 2024-12-03 | Warnings, Adverse reactions | OCTREOTIDE ACETATE OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Teva Pharmaceuticals, Inc. | d9739ea6-74de-4a41-a806-6e827a23cedb | 2024-07-30 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Gland Pharma Limited | 884e4287-a4d8-4a6e-8d99-dbe5e88875b9 | 2024-07-29 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Gland Pharma Limited | 2344ae7a-c2f0-433b-9133-1dcb16bb18a0 | 2024-07-25 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Mylan Institutional LLC | 2d78d5d1-77b2-4da1-98d4-d9c36e743ce2 | 2024-07-15 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
| Octreotide | OCTREOTIDE ACETATE | Fresenius Kabi USA, LLC | d6a9a800-889d-417f-b533-1913197d0022 | 2024-05-23 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide | OCTREOTIDE ACETATE | Fresenius Kabi USA, LLC | f278f0d8-4062-420a-97c3-3a8b88253a08 | 2024-05-07 | Warnings, Adverse reactions | OCTREOTIDE ACETATE |
| Octreotide Acetate | OCTREOTIDE ACETATE | Hikma Pharmaceuticals USA Inc. | 9502860d-0261-4d69-a4be-827a5376d356 | 2024-03-01 | Warnings, Adverse reactions | Octreotide Acetate OCTREOTIDE ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55648-632 | Octreotide acetate | Octreotide acetate | Wockhardt Limited | ANDA | Current |
| 55648-634 | Octreotide acetate | Octreotide acetate | Wockhardt Limited | ANDA | Current |
| 64679-632 | Octreotide acetate | Octreotide acetate | Wockhardt USA LLC. | ANDA | Current |
| 64679-634 | Octreotide acetate | Octreotide acetate | Wockhardt USA LLC. | ANDA | Current |